Posts Tagged ‘Medicaid’

The Gap in Patient Assistance for Obesity Medicines

September 7, 2024 — Recently, Novo Nordisk CEO Lars Fruergaard Jørgensen did a rare interview with NBC News to talk about the high price of obesity medicines that are proving to be so important for so many people. It seemed like a dress rehearsal for his coming appearance at a Senate hearing on the subject. He brought up the […]

Health Equity for a Price in Obesity Care

August 16, 2024 — Is the price for health equity in obesity care too high? Or do policy makers simply not care to make it a priority? Writing in the Washington Post, Reverend Al Sharpton tells us that advances in obesity care bring an appalling failure of health equity into plain view: “Despite rates of obesity among people of […]

Marginalizing People with the Greatest Need for Obesity Care

June 3, 2024 — The STOP Obesity Alliance released new data Friday from an exhaustive analysis of access to obesity medicines in Medicaid programs across the United States. It’s not a pretty picture. It gives us more data to show how we are marginalizing people with the greatest need for obesity care. No state fully covered all forms of […]

Are We Missing Our Chance for Better Equity in Obesity Care?

April 17, 2024 — GLP-1 agonists offer an opportunity to reduce health disparities, writes Karen Kaplan in the Los Angeles Times. But a problem with equity in obesity care is getting in the way. So instead, it seems they may be making things worse. Cardiologist and health services researcher Lauren Eberly tells Kaplan: “These patients have a higher burden […]

Adding Up the Cost of Untreated Obesity in Pennsylvania

March 20, 2024 — There is a hot debate playing out in medical journals and editorials all over the country. How can we pay for the advanced obesity medicines for which people are expressing such a great need? What often gets lost in this discussion is the fact that we are already paying. Yesterday, we had the good fortune […]

As Zepbound Launches, Will Access to Obesity Meds Improve?

December 6, 2023 — The Zepbound brand of tirzepatide is now available in U.S. pharmacies. This is a big deal because this launch marks the emergence of serious competition for advanced obesity medicines. Even (or perhaps especially) in healthcare, money indeed makes the world go around and one of the best checks on greed is competition. So as Zepbound […]

Paperwork, Insurance Tricks, and Tools for Health Disparity

July 22, 2023 — The administrative burden of healthcare is something that everyone experiences, but it hits people with social and economic disadvantages especially hard. Thus, paperwork and insurance tricks become tools for promoting health disparity that often escape notice. The Administrative Burden of American Healthcare A recent research brief from Health Affairs tells us that as much as […]

Persistent Pursuit of Access to Obesity Care

June 22, 2023 — It can be tedious. But the truth is that persistent pursuit of access to obesity care does indeed bring incremental progress. The latest case study came this week in Connecticut, with Governor Ned Lamont signing a bill into law to provide better access to obesity care under the state’s Medicaid program. Years of Effort This […]

Less Disparity in Obesity Care for Pennsylvania

October 25, 2022 — The world works in mysterious ways. Five years ago, a group of us that included ConscienHealth’s Ted Kyle went to Harrisburg to testify in favor of Pennsylvania taking a step toward less disparity in obesity care. Specifically, we were supporting a bill that State Representative Donna Oberlander (R-Clarion) was sponsoring to encourage coverage of obesity […]

A Pandemic Nudge for Better Access to Care

April 5, 2022 — We are close to reaching a million deaths from COVID in the U.S. Worldwide, the number passed six million a month ago and that number is a gross underestimate. So there can be no doubt that the pandemic has had a terrible effect on health everywhere. But in the midst of this tragedy, we can […]